- Home
- BMY vs MCO Comparison
BMY vs MCO Comparison
Compare BMY & MCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | MCO |
|---|---|---|
| Founded | 1887 | 1900 |
| Country | United States | United States |
| Employees | 32500 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.7B | 80.7B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | BMY | MCO |
|---|---|---|
| Price | $58.93 | $448.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 17 |
| Target Price | $62.13 | ★ $542.06 |
| AVG Volume (30 Days) | ★ 9.4M | 932.5K |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | ★ 4.35% | 0.92% |
| EPS Growth | N/A | ★ 21.40 |
| EPS | N/A | ★ 13.67 |
| Revenue | N/A | ★ $4,204,100,000.00 |
| Revenue This Year | N/A | $8.51 |
| Revenue Next Year | N/A | $7.76 |
| P/E Ratio | ★ $17.26 | $32.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $402.28 |
| 52 Week High | $62.89 | $546.88 |
Technical Indicators
Market Signals| Indicator | BMY | MCO |
|---|---|---|
| Relative Strength Index (RSI) | 49.65 | 53.51 |
| Support Level | $56.45 | $422.18 |
| Resistance Level | $62.39 | $450.66 |
| Average True Range (ATR) | 1.25 | 10.99 |
| MACD | -0.10 | 2.27 |
| Stochastic Oscillator | 34.07 | 78.37 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About MCO Moody's Corporation
Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed-income securities. The ratings segment, Moody's Investors Service, includes corporates, structured finance, financial institutions, and public finance ratings. MIS represents a majority of the firm's profit and often (depending on bond issuance levels) a majority of the firm's revenue. The other segment, Moody's Analytics, consists of decision solutions, research and insights, and data and information.